Research that changes how you train, eat, age, and treat — built on the largest clinical-grade body composition and metabolic dataset in the world.
of women on GLP-1 medications lose clinically significant lean mass — 1.6× the rate observed in men
is when bone mineral density begins its measurable decline in women — a full decade before most screening guidelines recommend testing
of adults with a "normal" BMI are metabolically obese on DEXA — carrying 1.4× higher cardiometabolic disease prevalence
Derived from hundreds of thousands of clinical-grade DEXA assessments. DexaFit Research, 2026.
Population-scale DEXA-derived reference ranges, stratified by age and sex from hundreds of thousands of clinical-grade assessments across four continents — establishing a new standard for body composition assessment.
Stay on top of what the data reveals in body composition, longevity, weight loss, and metabolic health — curated with the largest real-world dataset in the field.